Drug induced rhabdomyolysis

Current Opinion in Pharmacology

Volumn 12, Issue 3, 2012, Pages 335-339

  Hohenegger, Martin ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIHYDROPYRIDINE RECEPTOR; CALPAIN 3; CREATINE KINASE; DANTROLENE; DAPTOMYCIN; DEHYDRONIFEDIPINE; ERLOTINIB; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMATINIB; LEFLUNOMIDE; PROPOFOL; SIMVASTATIN; SUNITINIB; TRABECTEDIN;

ALOPECIA; ARTICLE; CALCIUM HOMEOSTASIS; CALCIUM TRANSPORT; CELL ORGANELLE; CITRIC ACID CYCLE; CONGESTIVE HEART FAILURE; CREATINE KINASE BLOOD LEVEL; DNA POLYMORPHISM; DRUG ANTAGONISM; DRUG HALF LIFE; DRUG INDUCED DISEASE; ENERGY YIELD; EXCITATION CONTRACTION COUPLING; FATTY ACID OXIDATION; GASTROINTESTINAL STROMAL TUMOR; GASTROINTESTINAL SYMPTOM; HEART LEFT VENTRICLE FAILURE; HUMAN; HYPERTENSION; KIDNEY CANCER; LEUKEMIA; LIVER TOXICITY; METASTASIS; MITOCHONDRIAL RESPIRATION; MULTIPLE CYCLE TREATMENT; MUSCLE INJURY; MUSCLE NECROSIS; MYOPATHY; MYOSITIS; OXIDATIVE PHOSPHORYLATION UNCOUPLING; PATHOGENESIS; PRIORITY JOURNAL; RESPIRATORY CHAIN; RHABDOMYOLYSIS; SARCOMA; SARCOPLASMIC RETICULUM; SIDE EFFECT; SKIN DISEASE;

EID: 84862290919     PISSN: 14714892     EISSN: 14714973     Source Type: Journal    
DOI: 10.1016/j.coph.2012.04.002     Document Type: Review

References (46)

1. O.S. Better, and Z.A. Abbassi Early fluid resuscitation in patients with rhabdomyolysis Nat Rev Nephrol 7 2011 416 422
2. W.S. David Myoglobinuria Neurol Clin 18 2000 215 243
3. M.S. Slater, and R.J. Mullins Rhabdomyolysis and myoglobinuric renal failure in trauma and surgical patients: a review J Am Coll Surg 186 1998 693 716
4. J.D. Warren, P.C. Blumbergs, and P.D. Thompson Rhabdomyolysis: a review Muscle Nerve 25 2002 332 347
5. P. Sirvent, J. Mercier, and A. Lacampagne New insights into mechanisms of statin-associated myotoxicity Curr Opin Pharmacol 8 2008 333 338
6. 2+ concentration during exertional rhabdomyolysis Lancet 345 1995 424 425
7. J. Sacher, L. Weigl, M. Werner, C. Szegedi, and M. Hohenegger Delineation of myotoxicity induced by 3-hydroxy-3-methylglutaryl CoA reductase inhibitors in human skeletal muscle cells J Pharmacol Exp Ther 314 2005 1032 1041
8. J.A. Duarte, J.M. Soares, and H.J. Appell Nifedipine diminishes exercise-induced muscle damage in mouse Int J Sports Med 13 1992 274 277
9. H.F. Ginz, S. Levano, T. Girard, A. Urwyler, and C. Hamel Dantrolene for severe rhabdomyolysis in Staphylococcus aureus toxic shock syndrome Eur J Anaesthesiol 29 2012 161 162
10. B.E. Grunau, M.O. Wiens, and M. Greidanus Dantrolene for the treatment of MDMA toxicity CJEM 12 2010 457 459
11. R.M. Murphy Calpains, skeletal muscle function and exercise Clin Exp Pharmacol Physiol 37 2010 385 391
12. R. Obata, Y. Yasumi, A. Suzuki, Y. Nakajima, and S. Sato Rhabdomyolysis in association with Duchenne's muscular dystrophy Can J Anaesth 46 1999 564 566
13. M.V. Micheletti, G. Lavoratti, S. Gasperini, M.A. Donati, and I. Pela Hemolytic uremic syndrome and rhabdomyolysis in a patient with succinate coenzyme Q reductase (complex II) deficiency Clin Nephrol 76 2011 68 73
14. G. Cervellin, I. Comelli, and G. Lippi Rhabdomyolysis: historical background, clinical, diagnostic and therapeutic features Clin Chem Lab Med 48 2010 749 756
15. S. Faivre, G. Demetri, W. Sargent, and E. Raymond Molecular basis for sunitinib efficacy and future clinical development Nat Rev Drug Discov 6 2007 734 745
16. T. Force, D.S. Krause, and R.A. Van Etten Molecular mechanisms of cardiotoxicity of tyrosine kinase inhibition Nat Rev Cancer 7 2007 332 344
17. H.R. Mellor, A.R. Bell, J.P. Valentin, and R.R. Roberts Cardiotoxicity associated with targeting kinase pathways in cancer Toxicol Sci 120 2011 14 32
18. R. Kerkela, K.C. Woulfe, J.B. Durand, R. Vagnozzi, D. Kramer, T.F. Chu, C. Beahm, M.H. Chen, and T. Force Sunitinib-induced cardiotoxicity is mediated by off-target inhibition of AMP-activated protein kinase Clin Transl Sci 2 2009 5 25
19. E.M. Ruggeri, F.L. Cecere, L. Moscetti, L. Doni, D. Padalino, and F. Di Costanzo Severe rhabdomyolysis during sunitinib treatment of metastatic renal cell carcinoma. A report of two cases Ann Oncol 21 2010 1926 1927
20. D. Strumberg, J.W. Clark, A. Awada, M.J. Moore, H. Richly, A. Hendlisz, H.W. Hirte, J.P. Eder, H.J. Lenz, and B. Schwartz Safety, pharmacokinetics, and preliminary antitumor activity of sorafenib: a review of four phase I trials in patients with advanced refractory solid tumors Oncologist 12 2007 426 437
21. G.S. Orphanos, G.N. Ioannidis, and A.G. Ardavanis Cardiotoxicity induced by tyrosine kinase inhibitors Acta Oncol 48 2009 964 970
22. A. Diaz-Sanchez, N. Rodriguez-Salas, T. Aramendi, and E. Balbin Myositis due to Sorafenib intake in a patient with hepatocellular carcinoma Dig Liver Dis 43 2011 333 334
23. J.K. Gordon, S.K. Magid, R.G. Maki, M. Fleisher, and E. Berman Elevations of creatine kinase in patients treated with imatinib mesylate (Gleevec) Leuk Res 34 2010 827 829
24. N. Penel, J.Y. Blay, and A. Adenis Imatinib as a possible cause of severe rhabdomyolysis N Engl J Med 358 2008 2746 2747
25. M. Veeraputhiran, and M. Sundermeyer Rhabdomyolysis resulting from pharmacologic interaction between erlotinib and simvastatin Clin Lung Cancer 9 2008 232 234
26. L. Moscetti, F. Nelli, and E.M. Ruggeri Rhabdomyolysis from erlotinib: a case report Tumori 97 2011 415 416
27. A. Skorupa, M. Beldner, A. Kraft, and A.J. Montero Fatal rhabdomyolysis as a complication of ET-743 (Yondelis) chemotherapy for sarcoma Cancer Biol Ther 6 2007 1015 1017
28. D.S. McMeekin, A. Lisyanskaya, M. Crispens, A.M. Oza, P. Braly, D. Doering, E. Bayever, B. Michiels, and M. Markman Single-agent trabectedin as second-line therapy of persistent or recurrent endometrial cancer: results of a multicenter phase II study Gynecol Oncol 114 2009 288 292
29. A. Stoyianni, N. Kapodistrias, E. Kampletsas, G. Pentheroudakis, and N. Pavlidis Trabectedin-related rhabdomyolysis: an uncommon but fatal toxicity Tumori 97 2011 252 255
30. S. Ochi, K. Taniguchi, and M. Nagashima Leflunomide-induced polymyositis in a patient with rheumatoid arthritis Mod Rheumatol 19 2009 443 446
31. H. Adamski, L. Lopez, E. Polard, J. Chevrant-Breton, and A. Dupuy Photodistributed eruption with rhabdomyolisis due to leflunomide Photodermatol Photoimmunol Photomed 27 2011 222 223
32. R. Sauermann, M. Rothenburger, W. Graninger, and C. Joukhadar Daptomycin: a review 4 years after first approval Pharmacology 81 2008 79 91
33. F. Sbrana, A. Di Paolo, E.M. Pasanisi, E. Tagliaferri, C. Arvia, M. Puntoni, A. Leonildi, F. Bigazzi, R. Danesi, D. Rovai C. Tascini, and F. Menichetti Administration interval and daptomycin toxicity: a case report of rhabdomyolysis J Chemother 22 2010 434 435
34. T.Y. Kostrominova, S. Coleman, F.B. Oleson, J.A. Faulkner, and L.M. Larkin Effect of daptomycin on primary rat muscle cell cultures in vitro In Vitro Cell Dev Biol Anim 46 2010 613 618
35. S. Papdopoulos, A.M. Ball, S.E. Liewer, C.A. Martin, P.S. Winstead, and B.S. Murphy Rhabdomyolysis during therapy with daptomycin Clin Infect Dis 42 2006 e108 e110
36. S.J. Patel, T.C. Samo, and W.N. Suki Early-onset rhabdomyolysis related to daptomycin use Int J Antimicrob Agents 30 2007 472 474
37. A. Kazory, K. Dibadj, and I.D. Weiner Rhabdomyolysis and acute renal failure in a patient treated with daptomycin J Antimicrob Chemother 57 2006 578 579
38. C.M. Edwards, K. King, and R.J. Garcia Early-onset rhabdomyolysis associated with daptomycin Infect Dis Clin Pract 14 2006 327 328
39. R.O. Odero, K.O. Cleveland, and M.S. Gelfand Rhabdomyolysis and acute renal failure associated with the co-administration of daptomycin and an HMG-CoA reductase inhibitor J Antimicrob Chemother 63 2009 1299 1300
40. B. Vasile, F. Rasulo, A. Candiani, and N. Latronico The pathophysiology of propofol infusion syndrome: a simple name for a complex syndrome Intensive Care Med 29 2003 1417 1425
41. S. Amrein, K. Amrein, A. Amegah-Sakotnik, U. Reist, and R. Ensner Propofol infusion syndrome - a critical incident report highlighting the danger of reexposure J Neurosurg Anesthesiol 23 2011 265 266
42. J. Motsch, and J. Roggenbach Propofol infusion syndrome Anaesthesist 53 2004 1009 1020
43. N. Mehta, C. DeMunter, P. Habibi, S. Nadel, and J. Britto Short-term propofol infusions in children Lancet 354 1999 866 867
44. K.A. Schenkman, and S. Yan Propofol impairment of mitochondrial respiration in isolated perfused guinea pig hearts determined by reflectance spectroscopy Crit Care Med 28 2000 172 177
45. A. Wolf, P. Weir, P. Segar, J. Stone, and J. Shield Impaired fatty acid oxidation in propofol infusion syndrome Lancet 357 2001 606 607
46. S. Vilar, R. Harpaz, H.S. Chase, S. Costanzi, R. Rabadan, and C. Friedman Facilitating adverse drug event detection in pharmacovigilance databases using molecular structure similarity: application to rhabdomyolysis J Am Med Inform Assoc 18 Suppl. 1 2011 i73 i80